{"transactions":[{"id":4624519,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-22T20:02:31.000Z","date":"2026-09-18","kind":"grant","planned":false,"acquired":true,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One third of the shares subject to this option vest on the one year anniversary of the grant date, and 1/36 of the shares subject to the option vest on each of the next 24 months thereafter provided that the Reporting Person is providing continuous services on the applicable vesting date."}],"balance_after":5750,"derivative":{"exercise_price":4.46,"expiration_date":"2036-09-18","underlying":"Common Stock","underlying_shares":5750},"source":{"system":"sec-edgar","filing":"0001193125-26-397873","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1619834/000119312526397873/ownership.xml","form_type":"4"}},{"id":4624518,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-22T20:02:31.000Z","date":"2026-09-18","kind":"grant","planned":false,"acquired":true,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of common stock for each RSU upon vesting. 1/3rd of the RSUs will vest annually on the anniversary of the date of grant, with the first 1/3rd vesting on September 18, 2027, provided that the Reporting Person is providing continuous services on the applicable vesting date."}],"balance_after":5750,"source":{"system":"sec-edgar","filing":"0001193125-26-397873","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619834/000119312526397873/ownership.xml","form_type":"4"}},{"id":919128,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-04T21:13:17.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":20701,"price":1.39,"value":28774.39,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2023."},{"field":"shares","element":"transactionShares","label":"F4","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2025."}],"balance_after":948432,"source":{"system":"sec-edgar","filing":"0001619834-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000161983426000002/primarydocument.xml","form_type":"4"}},{"id":919127,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-04T21:13:17.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":25375,"price":1.39,"value":35271.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2023."},{"field":"shares","element":"transactionShares","label":"F3","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2024."}],"balance_after":969133,"source":{"system":"sec-edgar","filing":"0001619834-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000161983426000002/primarydocument.xml","form_type":"4"}},{"id":919126,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-04T21:13:17.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":21582,"price":1.39,"value":29998.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2023."},{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2023."}],"balance_after":994508,"source":{"system":"sec-edgar","filing":"0001619834-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000161983426000002/primarydocument.xml","form_type":"4"}},{"id":921241,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2026-02-03T21:41:12.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":320000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date."}],"balance_after":320000,"derivative":{"exercise_price":1.41,"expiration_date":"2036-01-30","underlying":"Common Stock","underlying_shares":320000},"source":{"system":"sec-edgar","filing":"0001619834-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000161983426000001/primarydocument.xml","form_type":"4"}},{"id":921240,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-03T21:41:12.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":204000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan, as amended.   One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,500 shares of the Issuer's common stock purchased on June 30, 2025 and 1,500 shares of the Issuer's common stock purchased on December 31, 2025, each under the Issuer's Amended and Restated 2014 Employee Stock Purchase Plan."}],"balance_after":1016090,"source":{"system":"sec-edgar","filing":"0001619834-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000161983426000001/primarydocument.xml","form_type":"4"}},{"id":1226888,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-03-04T22:04:33.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":7144,"price":1.83,"value":13073.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022."},{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2023."}],"balance_after":809090,"source":{"system":"sec-edgar","filing":"0001562180-25-001997","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218025001997/primarydocument.xml","form_type":"4"}},{"id":1283960,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2025-02-04T22:53:09.000Z","date":"2025-01-31","kind":"grant","planned":true,"acquired":true,"shares":292300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date."}],"balance_after":292300,"derivative":{"exercise_price":2.24,"expiration_date":"2035-01-31","underlying":"Common Stock","underlying_shares":292300},"source":{"system":"sec-edgar","filing":"0001562180-25-000916","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218025000916/primarydocument.xml","form_type":"4"}},{"id":1283959,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-04T22:53:09.000Z","date":"2025-02-03","kind":"sale","planned":true,"acquired":false,"shares":27236,"price":2.1,"value":57195.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2023."},{"field":"shares","element":"transactionShares","label":"F5","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2024."}],"balance_after":816234,"source":{"system":"sec-edgar","filing":"0001562180-25-000916","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218025000916/primarydocument.xml","form_type":"4"}},{"id":1283958,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-04T22:53:09.000Z","date":"2025-02-03","kind":"sale","planned":true,"acquired":false,"shares":23270,"price":2.1,"value":48867.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2023."},{"field":"shares","element":"transactionShares","label":"F4","text":"This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2023."}],"balance_after":843470,"source":{"system":"sec-edgar","filing":"0001562180-25-000916","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218025000916/primarydocument.xml","form_type":"4"}},{"id":1283957,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-04T22:53:09.000Z","date":"2025-01-31","kind":"grant","planned":true,"acquired":true,"shares":194900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,500 shares of the Issuer's common stock purchased on June 28, 2024  and 1,500 shares of the Issuer's common stock purchased on December 31, 2024, each under the Issuer's Amended and Restated 2014 Employee Stock Purchase Plan."}],"balance_after":866740,"source":{"system":"sec-edgar","filing":"0001562180-25-000916","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218025000916/primarydocument.xml","form_type":"4"}},{"id":1521858,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-05-09T21:27:19.000Z","date":"2023-08-25","kind":"sale","planned":false,"acquired":false,"shares":27000,"price":1.15,"value":31050.0,"ownership":{"direct":true},"balance_after":668840,"source":{"system":"sec-edgar","filing":"0001562180-24-003948","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218024003948/primarydocument.xml","form_type":"4"}},{"id":1606385,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-03-01T22:46:51.000Z","date":"2024-02-29","kind":"sale","planned":false,"acquired":false,"shares":7169,"price":1.58,"value":11327.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022."}],"balance_after":695840,"source":{"system":"sec-edgar","filing":"0001562180-24-002020","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218024002020/primarydocument.xml","form_type":"4"}},{"id":1609562,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-29T23:01:46.000Z","date":"2024-02-27","kind":"sale","planned":true,"acquired":false,"shares":8367,"price":1.52,"value":12717.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021."},{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2023."}],"balance_after":703009,"source":{"system":"sec-edgar","filing":"0001562180-24-001993","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218024001993/primarydocument.xml","form_type":"4"}},{"id":1660929,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2024-02-02T21:10:01.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":303300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date."}],"balance_after":303300,"derivative":{"exercise_price":1.68,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":303300},"source":{"system":"sec-edgar","filing":"0001562180-24-000970","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218024000970/primarydocument.xml","form_type":"4"}},{"id":1660928,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-02T21:10:01.000Z","date":"2024-02-01","kind":"sale","planned":false,"acquired":false,"shares":24311,"price":1.68,"value":40842.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31,2023."}],"balance_after":711376,"source":{"system":"sec-edgar","filing":"0001562180-24-000970","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218024000970/primarydocument.xml","form_type":"4"}},{"id":1660927,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-02T21:10:01.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":202200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan.   One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,500 shares of the Issuer's common stock purchased on June 30, 2023 and 1,500 shares of the Issuer's common stock purchased on December 29, 2023, each under the Issuer's  Amended and Restated 2014 Employee Stock Purchase Plan."}],"balance_after":735687,"source":{"system":"sec-edgar","filing":"0001562180-24-000970","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218024000970/primarydocument.xml","form_type":"4"}},{"id":1886541,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-05-18T22:20:45.000Z","date":"2023-05-16","kind":"sale","planned":false,"acquired":false,"shares":63567,"price":1.068,"value":67889.556,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made automatically by the Issuer pursuant to the Issuer's previously adopted \"sell-to-cover\" policy to cover tax withholding obligations in connection with the vesting and settlement of 100% of the reporting person's restricted stock units granted on May 12, 2022."}],"balance_after":530487,"source":{"system":"sec-edgar","filing":"0001562180-23-004254","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218023004254/primarydocument.xml","form_type":"4"}},{"id":1971968,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-03-03T13:01:13.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":1110,"price":0.8775,"value":974.025,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021."}],"balance_after":594054,"source":{"system":"sec-edgar","filing":"0001562180-23-002199","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218023002199/primarydocument.xml","form_type":"4"}},{"id":1971967,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-03-03T13:01:13.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":6400,"price":0.8775,"value":5616.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022."}],"balance_after":595164,"source":{"system":"sec-edgar","filing":"0001562180-23-002199","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218023002199/primarydocument.xml","form_type":"4"}},{"id":1971966,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-03-03T13:01:13.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":6613,"price":0.8775,"value":5802.9075,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2020."}],"balance_after":601564,"source":{"system":"sec-edgar","filing":"0001562180-23-002199","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218023002199/primarydocument.xml","form_type":"4"}},{"id":1983108,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-03-01T21:06:40.000Z","date":"2023-02-27","kind":"sale","acquired":false,"shares":7539,"price":0.8132,"value":6130.7148,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021."}],"balance_after":608177,"source":{"system":"sec-edgar","filing":"0001562180-23-002040","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218023002040/primarydocument.xml","form_type":"4"}},{"id":2035280,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2023-02-02T21:14:30.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":294300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date."}],"balance_after":294300,"derivative":{"exercise_price":0.63,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":294300},"source":{"system":"sec-edgar","filing":"0001562180-23-000830","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218023000830/primarydocument.xml","form_type":"4"}},{"id":2035279,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-02-02T21:14:30.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":196200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,500 shares of the Issuer's common stock purchased on December 30, 2022 under the Issuer's 2014 Amended and Restated Employee Stock Purchase Plan."}],"balance_after":615716,"source":{"system":"sec-edgar","filing":"0001562180-23-000830","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218023000830/primarydocument.xml","form_type":"4"}},{"id":2168788,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-09-01T20:15:30.000Z","date":"2022-08-31","kind":"sale","acquired":false,"shares":1147,"price":0.3625,"value":415.7875,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on August 30, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,500 shares of the Issuer's common stock purchased on June 30, 2022, under the Issuer's 2014 Amended and Restated Employee Stock Purchase Plan."}],"balance_after":418016,"source":{"system":"sec-edgar","filing":"0001562180-22-006402","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218022006402/primarydocument.xml","form_type":"4"}},{"id":2269882,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2022-05-16T20:08:28.000Z","date":"2022-05-12","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest in full on the first anniversary of the grant date, subject to the reporting person's continued service with the Issuer on such vesting date."}],"balance_after":200000,"derivative":{"exercise_price":0.41,"exercise_date":"2023-05-12","expiration_date":"2032-05-12","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001562180-22-004031","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218022004031/primarydocument.xml","form_type":"4"}},{"id":2269881,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-05-16T20:08:28.000Z","date":"2022-05-12","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The restricted stock units will vest in full on the first anniversary of the grant date, subject to the reporting person's continued service with the Issuer on such vesting date."}],"balance_after":417663,"source":{"system":"sec-edgar","filing":"0001562180-22-004031","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218022004031/primarydocument.xml","form_type":"4"}},{"id":2359632,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2022-03-03T02:12:48.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date."}],"balance_after":225000,"derivative":{"exercise_price":2.16,"expiration_date":"2032-02-28","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001562180-22-002165","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218022002165/primarydocument.xml","form_type":"4"}},{"id":2359631,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-03-03T02:12:48.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":1100,"price":2.1707,"value":2387.77,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 1,500 shares of the Issuers common stock purchased on December 31, 2021, under the Issuers 2014 Amended and Restated Employee Stock Purchase Plan."}],"balance_after":217663,"source":{"system":"sec-edgar","filing":"0001562180-22-002165","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218022002165/primarydocument.xml","form_type":"4"}},{"id":2359630,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-03-03T02:12:48.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":6556,"price":2.1707,"value":14231.1092,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2020."}],"balance_after":217263,"source":{"system":"sec-edgar","filing":"0001562180-22-002165","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218022002165/primarydocument.xml","form_type":"4"}},{"id":2359629,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-03-03T02:12:48.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One-third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date."}],"balance_after":223819,"source":{"system":"sec-edgar","filing":"0001562180-22-002165","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218022002165/primarydocument.xml","form_type":"4"}},{"id":2359628,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-03-03T02:12:48.000Z","date":"2022-02-28","kind":"sale","acquired":false,"shares":7400,"price":2.1548,"value":15945.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021."}],"balance_after":163819,"source":{"system":"sec-edgar","filing":"0001562180-22-002165","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218022002165/primarydocument.xml","form_type":"4"}},{"id":2581125,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-09-02T20:07:50.000Z","date":"2021-08-31","kind":"sale","acquired":false,"shares":1042,"price":2.83,"value":2948.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on August 30, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,500 shares of the Issuer's common stock purchased on June 30, 2021 under the Issuer's 2014 Amended and Restated Employee Stock Purchase Plan."}],"balance_after":171219,"source":{"system":"sec-edgar","filing":"0001562180-21-005744","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218021005744/primarydocument.xml","form_type":"4"}},{"id":2763443,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-02T00:31:40.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":1081,"price":3.4,"value":3675.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021."}],"balance_after":170761,"source":{"system":"sec-edgar","filing":"0001562180-21-002539","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218021002539/primarydocument.xml","form_type":"4"}},{"id":2778762,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-03-18T23:16:26.000Z","date":"2021-03-16","kind":"grant","acquired":true,"shares":10400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"As previously disclosed, in February 2020, the Reporting Person was granted performance-based restricted stock unit awards (\"PSUs\") pursuant to the Issuer's 2014 Incentive Plan, as amended. The PSUs vest in connection with the achievement of specified commercial and regulatory milestones. On February 25, 2021, the Company reported its financial results for the year ended December 31, 2020.  Subsequently, in accordance with the terms of the grant, the Issuer's Compensation Committee certified the achievement of a commercial milestone and, as a result, one third of the reported PSUs will vest on each of March 31, 2021, February 28, 2022 and February 28, 2023, subject to the Reporting Person's continued service with the Issuer on each vesting date."}],"balance_after":171842,"source":{"system":"sec-edgar","filing":"0001562180-21-002353","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218021002353/primarydocument.xml","form_type":"4"}},{"id":2818968,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2021-03-02T21:06:49.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date."}],"balance_after":120000,"derivative":{"exercise_price":3.46,"expiration_date":"2031-02-26","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001562180-21-001781","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218021001781/primarydocument.xml","form_type":"4"}},{"id":2818967,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-03-02T21:06:49.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":7558,"price":3.3961,"value":25667.7238,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2020."}],"balance_after":161442,"source":{"system":"sec-edgar","filing":"0001562180-21-001781","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218021001781/primarydocument.xml","form_type":"4"}},{"id":2818966,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-03-02T21:06:49.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date."}],"balance_after":169000,"source":{"system":"sec-edgar","filing":"0001562180-21-001781","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218021001781/primarydocument.xml","form_type":"4"}},{"id":3237401,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2020-03-03T00:25:37.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":105500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter."}],"balance_after":105500,"derivative":{"exercise_price":8.87,"expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":105500},"source":{"system":"sec-edgar","filing":"0001562180-20-001930","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218020001930/primarydocument.xml","form_type":"4"}},{"id":3237400,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-03-03T00:25:37.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":62000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date."}],"balance_after":99000,"source":{"system":"sec-edgar","filing":"0001562180-20-001930","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218020001930/primarydocument.xml","form_type":"4"}},{"id":3360834,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-22T11:19:51.000Z","date":"2019-11-20","kind":"purchase","acquired":true,"shares":27000,"price":3.58,"value":96660.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The purchase reported in this Form 4 was made on the open market."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.50 to $3.64, inclusive. The reporting person undertakes to provide Issuer, any security holder of Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote."}],"balance_after":37000,"source":{"system":"sec-edgar","filing":"0001562180-19-005640","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218019005640/primarydocument.xml","form_type":"4"}},{"id":3422914,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2019-09-04T20:03:05.000Z","date":"2019-08-30","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were granted by the Issuer as an inducement material to the reporting person's entering into employment with the Issuer in accordance with Nasdaq Listing Rule 5635(c)(4).  The options will vest over four years:  25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter."}],"balance_after":250000,"derivative":{"exercise_price":4.13,"expiration_date":"2029-08-30","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001562180-19-004618","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218019004618/primarydocument.xml","form_type":"4"}},{"id":3422913,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-09-04T20:03:05.000Z","date":"2019-08-30","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended.  One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001562180-19-004618","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218019004618/primarydocument.xml","form_type":"4"}},{"id":3590131,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-03-18T12:15:41.000Z","date":"2019-03-15","kind":"gift","acquired":true,"shares":7333,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."},{"field":"shares","element":"transactionShares","label":"F3","text":"This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."}],"balance_after":26332,"source":{"system":"sec-edgar","filing":"0001171843-19-001780","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184319001780/ownership.xml","form_type":"4"}},{"id":3590130,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-03-18T12:15:41.000Z","date":"2019-03-15","kind":"gift","acquired":true,"shares":7333,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."},{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."}],"balance_after":18999,"source":{"system":"sec-edgar","filing":"0001171843-19-001780","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184319001780/ownership.xml","form_type":"4"}},{"id":3590129,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-03-18T12:15:41.000Z","date":"2019-03-15","kind":"gift","acquired":false,"shares":7333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."},{"field":"shares","element":"transactionShares","label":"F3","text":"This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."}],"balance_after":101917,"source":{"system":"sec-edgar","filing":"0001171843-19-001780","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184319001780/ownership.xml","form_type":"4"}},{"id":3590128,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-03-18T12:15:41.000Z","date":"2019-03-15","kind":"gift","acquired":false,"shares":7333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."},{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."}],"balance_after":109251,"source":{"system":"sec-edgar","filing":"0001171843-19-001780","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184319001780/ownership.xml","form_type":"4"}},{"id":3590127,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-03-18T12:15:41.000Z","date":"2019-03-15","kind":"gift","acquired":false,"shares":7334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of securities by the reporting person to the William Conroy Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."},{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction involved a gift of securities by the reporting person to the William Conroy Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."}],"balance_after":116584,"source":{"system":"sec-edgar","filing":"0001171843-19-001780","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184319001780/ownership.xml","form_type":"4"}},{"id":3689140,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-23T21:17:59.000Z","date":"2019-01-18","kind":"grant","acquired":true,"shares":145000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on January 18, 2019 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments."}],"balance_after":145000,"derivative":{"exercise_price":2.64,"expiration_date":"2029-01-17","underlying":"Common Stock, $0.001 par value","underlying_shares":145000},"source":{"system":"sec-edgar","filing":"0001171843-19-000435","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184319000435/ownership.xml","form_type":"4"}},{"id":3707806,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-01-03T13:19:08.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":2448,"price":1.93,"value":4724.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan for the plan period of July 1, 2018 through December 31, 2018 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":123917,"source":{"system":"sec-edgar","filing":"0001171843-19-000063","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184319000063/ownership.xml","form_type":"4"}},{"id":3874247,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-07-03T12:19:17.000Z","date":"2018-06-29","kind":"grant","acquired":false,"shares":10000,"price":1.615,"value":16150.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan for the plan period of January 1, 2018 through June 30, 2018 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":121469,"source":{"system":"sec-edgar","filing":"0001171843-18-004988","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184318004988/formfour.xml","form_type":"4"}},{"id":4095793,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-18T22:16:29.000Z","date":"2018-01-17","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on January 17, 2018 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments."}],"balance_after":200000,"derivative":{"exercise_price":2.85,"expiration_date":"2028-01-16","underlying":"Common Stock, $0.001 par value","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001171843-18-000440","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184318000440/formfour.xml","form_type":"4"}},{"id":4110761,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-01-03T13:15:39.000Z","date":"2017-12-29","kind":"grant","acquired":false,"shares":3934,"price":1.296,"value":5098.464,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan for the plan period of July 1, 2017 through December 31, 2017 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":111469,"source":{"system":"sec-edgar","filing":"0001171843-18-000081","document":"form4burke.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184318000081/form4burke.xml","form_type":"4"}},{"id":4128337,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-12-18T22:11:00.000Z","date":"2017-12-15","kind":"gift","acquired":true,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."},{"field":"shares","element":"transactionShares","label":"F4","text":"This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."}],"balance_after":11666,"source":{"system":"sec-edgar","filing":"0001171843-17-007734","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184317007734/formfour.xml","form_type":"4"}},{"id":4128336,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-12-18T22:11:00.000Z","date":"2017-12-15","kind":"gift","acquired":true,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."},{"field":"shares","element":"transactionShares","label":"F3","text":"This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."}],"balance_after":8333,"source":{"system":"sec-edgar","filing":"0001171843-17-007734","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184317007734/formfour.xml","form_type":"4"}},{"id":4128335,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-12-18T22:11:00.000Z","date":"2017-12-15","kind":"gift","acquired":false,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."},{"field":"shares","element":"transactionShares","label":"F4","text":"This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."}],"balance_after":107535,"source":{"system":"sec-edgar","filing":"0001171843-17-007734","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184317007734/formfour.xml","form_type":"4"}},{"id":4128334,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-12-18T22:11:00.000Z","date":"2017-12-15","kind":"gift","acquired":false,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."},{"field":"shares","element":"transactionShares","label":"F3","text":"This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."}],"balance_after":110868,"source":{"system":"sec-edgar","filing":"0001171843-17-007734","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184317007734/formfour.xml","form_type":"4"}},{"id":4128333,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-12-18T22:11:00.000Z","date":"2017-12-15","kind":"gift","acquired":false,"shares":3334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction involved a gift of securities by the reporting person to the William Conroy Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."},{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction involved a gift of securities by the reporting person to the William Conroy Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."}],"balance_after":114201,"source":{"system":"sec-edgar","filing":"0001171843-17-007734","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184317007734/formfour.xml","form_type":"4"}},{"id":4128332,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-12-18T22:11:00.000Z","date":"2017-12-15","kind":"purchase","acquired":true,"shares":12000,"price":1.88,"value":22560.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase price of $1.88 is reflective of the weighted average purchase price of all transactions reported on this line. The prices for the transactions reported on this line range from $1.875 to $1.9. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":117535,"source":{"system":"sec-edgar","filing":"0001171843-17-007734","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184317007734/formfour.xml","form_type":"4"}},{"id":4263513,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-07-05T20:10:19.000Z","date":"2017-06-30","kind":"grant","acquired":false,"shares":10000,"price":1.296,"value":12960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":105535,"source":{"system":"sec-edgar","filing":"0001171843-17-003951","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184317003951/formfour.xml","form_type":"4"}},{"id":4388312,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-13T21:00:24.000Z","date":"2017-03-10","kind":"exercise","acquired":false,"shares":57934,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on October 26, 2011. All shares underlying the option have vested."}],"balance_after":0,"derivative":{"exercise_price":1.27,"expiration_date":"2021-10-25","underlying":"Common Stock, $0.001 par value","underlying_shares":57934},"source":{"system":"sec-edgar","filing":"0001171843-17-001479","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184317001479/form4.xml","form_type":"4"}},{"id":4388311,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-13T21:00:24.000Z","date":"2017-03-10","kind":"exercise","acquired":false,"shares":12287,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on September 10, 2007. All shares underlying the option have vested."}],"balance_after":0,"derivative":{"exercise_price":2.38,"expiration_date":"2017-09-09","underlying":"Common Stock, $0.001 par value","underlying_shares":12287},"source":{"system":"sec-edgar","filing":"0001171843-17-001479","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184317001479/form4.xml","form_type":"4"}},{"id":4388310,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-03-13T21:00:24.000Z","date":"2017-03-10","kind":"exercise","acquired":true,"shares":57934,"price":1.27,"value":73576.18,"ownership":{"direct":true},"balance_after":95535,"source":{"system":"sec-edgar","filing":"0001171843-17-001479","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184317001479/form4.xml","form_type":"4"}},{"id":4388309,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-03-13T21:00:24.000Z","date":"2017-03-10","kind":"exercise","acquired":true,"shares":12287,"price":2.38,"value":29243.06,"ownership":{"direct":true},"balance_after":37601,"source":{"system":"sec-edgar","filing":"0001171843-17-001479","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184317001479/form4.xml","form_type":"4"}},{"id":4480349,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-26T13:00:27.000Z","date":"2017-01-24","kind":"grant","acquired":true,"shares":53119,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on January 24, 2017 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments."}],"balance_after":53119,"derivative":{"exercise_price":2.05,"expiration_date":"2027-01-23","underlying":"Common Stock, $0.001 par value","underlying_shares":53119},"source":{"system":"sec-edgar","filing":"0001171843-17-000451","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184317000451/formfour.xml","form_type":"4"}},{"id":4530992,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2016-12-06T21:30:15.000Z","date":"2016-12-02","kind":"gift","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."},{"field":"shares","element":"transactionShares","label":"F3","text":"This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001171843-16-013526","document":"f4_burke120616.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184316013526/f4_burke120616.xml","form_type":"4"}},{"id":4530991,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2016-12-06T21:30:15.000Z","date":"2016-12-02","kind":"gift","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."},{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001171843-16-013526","document":"f4_burke120616.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184316013526/f4_burke120616.xml","form_type":"4"}},{"id":4530990,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2016-12-06T21:30:15.000Z","date":"2016-12-02","kind":"gift","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."},{"field":"shares","element":"transactionShares","label":"F3","text":"This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."}],"balance_after":25314,"source":{"system":"sec-edgar","filing":"0001171843-16-013526","document":"f4_burke120616.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184316013526/f4_burke120616.xml","form_type":"4"}},{"id":4530989,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2016-12-06T21:30:15.000Z","date":"2016-12-02","kind":"gift","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."},{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."}],"balance_after":27814,"source":{"system":"sec-edgar","filing":"0001171843-16-013526","document":"f4_burke120616.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184316013526/f4_burke120616.xml","form_type":"4"}},{"id":4530988,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":67721,"kind":"person","name":"Burke Steven Keith","position":1,"cik":"0001619834","reported_name":"Burke Steven Keith","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2016-12-06T21:30:15.000Z","date":"2016-12-02","kind":"gift","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of securities by the reporting person to the William Conroy Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."},{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction involved a gift of securities by the reporting person to the William Conroy Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose."}],"balance_after":30314,"source":{"system":"sec-edgar","filing":"0001171843-16-013526","document":"f4_burke120616.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000117184316013526/f4_burke120616.xml","form_type":"4"}}]}